$OKLO

DeWitte Jacob sold $1.7M of OKLO

DeWitte Jacob (Co-Founder, CEO) sold 40,000 shares of Oklo Inc. (OKLO) at $41.68 ($1.67M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Aug 5, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosed sale amount and execution price may influence short-term sentiment, but the stated 10b5-1 pre-arranged plan generally lowers the signal strength for fundamentals.

02

Market read

Traders may monitor insider selling activity, but this specific disclosure is unlikely to drive a major repricing absent additional corroborating news.

03

What to watch

The article provides only one sale event; without a pattern of prior filings, it is hard to infer whether this is routine liquidity versus a change in insider behavior.

Relevance 5/10Novelty 3/10Timing: Form 4 filed Aug 5, covering an Aug 3 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for Oklo Inc., reported by its co-founder and CEO.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo co-founder and CEO DeWitte Jacob sold 40,000 shares on Aug 3 at $41.68 via a 10b5-1 plan, per Form 4 filed Aug 5.

Expected impact

Limited near-term impact expected; any effect is likely short-lived unless follow-on filings show unusual selling beyond planned activity.

Evidence & confidence

The filing discloses sale size, price, and that it was executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated or large insider sales can still be interpreted by some traders as confidence erosion, especially in early-stage growth names.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale disclosure.

  • DeWitte Jacob

    Co-Founder, CEO, and reporting insider who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OKLOMed

UBS cuts Oklo stock price target to $41 on estimate updates

UBS reduced its price target for Oklo Inc. (NYSE:OKLO) to $41 from $55, citing updated estimates and maintaining a Neutral rating. The stock is down 68% over the past year. Oklo reported a wider-than-expected Q2 2026 loss but exceeded revenue forecasts, with $3.0 billion in cash. The company launched a $1 billion stock offering program. UBS and Truist Securities highlight near-term execution risks and progress in projects.

$OKLOMedAI 8/10

OKLO, XE Stocks Jump After-Hours — Trump Administration Taps Oklo, X-Energy In $200M Push To Power AI Data Centers

Oklo Inc. (OKLO) and X-Energy Inc. (XE) gained in after-hours trading after joining a $200M federal initiative to build nuclear power plants for AI data centers. The program includes Microsoft (MSFT) and Nvidia (NVDA), with $60M allocated to labs and universities. The initiative aims to accelerate reactor construction and reduce staffing needs, addressing rising electricity demand and grid strain.

$OKLOHigh

Nuclear Stocks Oklo, NuScale Power, and X

Shares of Oklo (OKLO), NuScale Power (SMR), and X-Energy (XE) surged after the U.S. House passed the Ratepayer Protection Act, which may boost demand for their small modular reactors as data center power sources. XE stock rose 12.08% to $16.33. Analysts see 106% upside for XE, with a $33.71 average price target.